Takashi Nakanoma
Saitama Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takashi Nakanoma.
International Journal of Urology | 1999
Takashi Ohigashi; Shoichi Nonaka; Takashi Nakanoma; Munehisa Ueno; Nobuhiro Deguchi
Purpose/Methods: We report on a case of retroperitoneal benign schwannoma treated by laparoscopic surgery.
International Journal of Urology | 2000
Munehisa Ueno; Shin-Ichi Ban; Takashi Ohigashi; Takashi Nakanoma; Shoichi Nonaka; Risa Hirata; Masahiro Iida; Nobuhiro Deguchi
A case of bladder cancer with simultaneous production of granulocyte colony‐stimulating factor (G‐CSF) and parathyroid hormone‐related protein (PTHrP) is reported. An 81‐year‐old male patient was admitted to the Saitama Medical School for treatment of gross hematuria, leukocytosis and hypercalcemia and diagnosed as having advanced bladder cancer. Immediately after a cystectomy was carried out, his white cell count and serum calcium levels returned to normal. However, the tumors recurred locally and the recurrence was accompanied by an increase in the serum G‐CSF and PTHrP levels with a recurrent elevation of white cell count and the serum calcium level. The production of G‐CSF and PTHrP in the tumor cells was confirmed by immunohistochemistry.
Urologia Internationalis | 2007
Minoru Horinaga; Koji Kitamura; Shiro Saito; Osamu Ukimura; Takashi Nakanoma; Koji Okihara; Motonobu Kitagawa; Hiroyuki Nakanishi; Tsuneharu Miki
Background/Aims: The diagnostic validity of prostate-specific antigen (PSA) among men receiving hemodialysis (HD) has not been well defined. The aim of this study was to evaluate PSA levels in HD men and to compare them with those of non-uremic controls. Methods: PSA levels were measured in 620 HD men (40–89 years old, mean age 62.4 years). In patients with PSA >4.1 ng/ml, prostate biopsies were performed. Cancer-free men were defined as having PSA ranging between 0 and 4.0 ng/ml, or PSA >4.1 ng/ml but with a pathologically negative biopsy. The resulting data was compared with that for 3,636 non-uremic controls (55–59- (n = 468), 60–69- (n = 2,220), and 70–79-year-old men (n = 948)). Results: Of 45 HD men with PSA >4.1 ng/ml, 22 consented to undergo a biopsy. Ten were positive and 12 were negative. The mean PSA of cancer-free HD men of 50–59 (n = 159), 60–69 (n = 214), 70–79 (n = 116), and 80–89 (n = 30) were 1.0, 1.0, 1.3, and 2.1 ng/ml, respectively. Cancer-free HD men demonstrated significantly lower PSA compared to controls. Conclusions: HD men had lower PSA levels than those of controls.
International Journal of Urology | 2001
Munehisa Ueno; Jun Nakashima; Masumi Akita; Shin-Ichi Ban; Takashi Nakanoma; Masahiro Iida; Nobuhiro Deguchi
Abstract Background: ACT‐1, a new cell line of human adrenocortical carcinoma, has been established and successfully maintained in culture. This study examined the biological characteristics of the cells.
International Journal of Urology | 2000
Munehisa Ueno; Shin-Ichi Ban; Takashi Nakanoma; Takuji Tsukamoto; Shoichi Nonaka; Risa Hirata; Masahiro Iida; Nobuhiro Deguchi
A patient with renal cell carcinoma who developed humoral hypercalcemia of malignancy is reported. A 52‐year‐old male patient was diagnosed with renal cell carcinoma and multiple lung metastases. A cell line isolated from the surgical specimen exhibited continuous production of parathyroid hormone‐related protein (PTHrP) in vitro. The production of PTHrP from the cancer cells was confirmed by RT‐PCR and immunoradiometric assay. The serum calcium level was not enhanced, whereas the lung lesion was developing and producing interleukin‐6, a possible modulator of osteoclastic resorption. Hypercalcemia was induced when the PTHrP concentration increased up to 3.3 pmol/L.
International Journal of Urology | 1999
Takashi Ohigashi; Munehisa Ueno; Masahiro Iida; Risa Hirata; Takashi Nakanoma; Nobuhiro Deguchi
Background: The significance of apoptosis with regard to the development and progression of androgen‐dependent cells has not been clearly understood. In the present study we investigated the expression of the bcl‐2 proto‐oncogene after androgen deprivation and its role in cell growth in an androgen‐dependent cell line.
Urology | 2006
Minoru Horinaga; Jun Nakashima; Takashi Nakanoma
American Journal of Physiology-cell Physiology | 2000
Takashi Ohigashi; Munehisa Ueno; Shoichi Nonaka; Takashi Nakanoma; Yusuke Furukawa; Nobuhiro Deguchi; Masaru Murai
The Japanese Journal of Urology | 2001
Takashi Nakanoma; Munehisa Ueno; Shoichi Nonaka; Takuji Tsukamoto; Nobuhiro Deguchi
The Japanese Journal of Urology | 1998
Takashi Ohigashi; Shoichi Nonaka; Takashi Nakanoma; Munehisa Ueno; Nobuhiro Deguchi